Immunovia AB Receivables

The latest receivables for IMMVF is $2.8M as of June 2026. That compares with $350K in the prior-year period — up 712.7% year over year. Investors often review this figure alongside Immunovia AB's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMMVF's receivables moved from $350K to $2.8M — a 712.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Immunovia AB's operating scale or balance-sheet position.

A receivables figure of $2.8M for IMMVF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IMMVF's receivables ($2.8M), review year-over-year change from $350K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.